Thermo Fisher Scientific Inc. (TMO)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 32 | 39 | 45 | 43 | 43 | 45 | 46 | 48 |
| Operating profit | $bn | 8 | 8 | ||||||
| Net profit | $bn | 6 | 8 | 7 | 6 | 6 | 7 | 7 | 9 |
| EPS reported | $ | 17.74 | 18.59 | ||||||
| Operating cashflow per share | $ | 20.79 | 24.29 | ||||||
| Capex per share | $ | 4.06 | 4.57 | ||||||
| FCF per share | $ | 16.74 | 19.73 | ||||||
| Free cash flow | $bn | 6 | 7 | ||||||
| Net debt | $bn | 29 | -1 | ||||||
| Book value equity | $bn | 53 | 53 | ||||||
| Book value per share | $ | 141.7 | 142.0 | ||||||
| Number of shares | m | 377 | 371 | ||||||
| DPS (TTM paid) | $ | 1.72 | 1.84 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 32.66 | 36.31 | ||||||
| P/B LTM | x | 4.08 | 4.14 | ||||||
| P/S LTM | x | 4.89 | 4.70 | ||||||
| P/FCF LTM | x | 34.62 | 29.77 | ||||||
| EV/EBITDA LTM | x | 21.58 | 22.63 | ||||||
| EV/Sales LTM | x | 5.55 | 5.62 | ||||||
| Earnings Yield LTM | % | +3.06% | +2.75% | ||||||
| FCF Yield | % | +2.89% | +3.36% | ||||||
| Quality | |||||||||
| ROE | % | +12.61% | +13.35% | ||||||
| ROIC | % | +7.60% | +7.44% | ||||||
| Operating margin | % | +18.20% | +17.69% | ||||||
| Gross margin | % | +40.93% | +40.37% | ||||||
| FCF/Sales | % | +14.12% | +15.79% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +7.32% | +12.46% | ||||||
| Sales Growth YoY | % | +3.91% | +8.06% | ||||||
| Net Income Growth YoY | % | +6.35% | +10.15% | ||||||
| FCF Growth | % | -13.40% | +0.70% | ||||||
| Operating Profit Growth | % | +5.83% | +8.68% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.29% | +0.30% | ||||||
| Dividend Growth | % | +10.26% | +17.95% | ||||||
| Payout Ratio | % | +9.51% | +9.50% | ||||||
| FCF/Debt | x | 0.16 | 0.17 | ||||||
| Net Debt/EBITDA | x | 2.58 | 3.52 | ||||||
| EBIT/Net interest | x | 5.71 | 5.59 | ||||||
| Net debt/market cap | % | +18.08% | +19.19% | ||||||
| Net debt/Equity | x | 0.55 | -0.01 | ||||||
| Gross debt/equity | x | 0.74 | 0.81 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Thermo Fisher Scientific Inc. (TMO)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free